ETF PRO AINovember 17, 2026
PBE Invesco Dynamic Biotechnology & Genome ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.59%expense ratio
$434Mfund assets
+16.6%return, YTD
—return, 1 year
+$10Mnet flow, 1 month
+$122Mnet flow, 1 year
20.4%realized volatility, 1y
-11.8%worst drawdown, 1y
Top ten holdings
| 1 | REGN REGENERON PHARMACEUTICALS | 5.78% |
| 2 | BIIB BIOGEN | 5.78% |
| 3 | GILD GILEAD SCIENCES | 5.69% |
| 4 | RPRX ROYALTY PHARMA | 5.63% |
| 5 | AMGN AMGEN | 5.31% |
| 6 | VRTX VERTEX PHARMACEUTICALS | 4.91% |
| 7 | ILMN ILLUMINA | 4.64% |
| 8 | NTRA NATERA | 4.78% |
| 9 | MRNA MODERNA | 3.87% |
| 10 | VCEL VERICEL | 3.62% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS